Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating liraglutide in patients with Maturity-onset diabetes of the young (MODY), currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Mansa | Conditions: Maturity Onset Diabetes of the Young | Phase 2 | Status: RECRUITING